Global Expansion OrbusNeich serves over 70 countries and regions and is actively expanding into structural heart disease, presenting a broad international opportunity across PCI, PTA, and emerging structural heart segments.

Product Portfolio A diverse, proprietary lineup including Sapphire and Scoreflex balloons, COMBO dual-therapy stents, sirolimus-eluting stents, paclitaxel-coated balloons, and advanced catheters positions the company to cross-sell multiple interventional technologies across hospital departments.

Strong Growth Signals Revenue range of 500 million to 1 billion with a substantial funding base implies financial robustness that can support broader sales initiatives, training, and larger regional deployments.

Awards & Recognition Recent industry accolades for outstanding medical device solutions and globalization highlight credibility with customers and potential partners, aiding market entry and key account conversations.

R&D & Innovation In-house R&D with over 20 years of product development expertise suggests a capability to support custom needs, clinical evidence generation, and rapid adoption of new interventional technologies.